Valuation: MatsukiyoCocokara & Co.

Capitalization 902B 5.63B 4.87B 4.47B 4.21B 7.84B 536B 7.96B 53.15B 20.69B 259B 21.13B 20.67B P/E ratio 2026
18.1x
P/E ratio 2027 * 15x
Enterprise value 781B 4.87B 4.22B 3.87B 3.64B 6.78B 464B 6.89B 46.01B 17.9B 224B 18.29B 17.89B EV / Sales 2026
0.8x
EV / Sales 2027 * 0.67x
Free-Float
83.11%
Yield 2026
1.98%
Yield 2027 * 2.48%
05-14 MatsukiyoCocokara & Co.'s Equity Buyback announced on May 13, 2026, has closed with 4,617,700 shares, representing 1.16% for ¥10,745.39 million. CI
05-14 Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 13, 2026. CI
05-14 Matsukiyococokara & Co - to retire treasury shares worth 1.16% of outstanding stock on May 29 RE
05-13 MatsukiyoCocokara & Co. announces an Equity Buyback for 5,000,000 shares, representing 1.26% for ¥11,635 million. CI
05-13 Matsukiyococokara & Co. Provides Consolidated Earnings Guidance for the Fiscal First Half Ending September 30, 2026 and Full Year Ending March 31, 2027 CI
05-13 Matsukiyococokara & Co. Revises Dividend for the Fiscal Full Year Ended March 31, 2026, Payable on June 22, 2026; Provides Dividend Guidance for the Second Quarter and Fiscal Year-Ending March 31, 2027 CI
05-13 MatsukiyoCocokara & Co. Reports Earnings Results for the Full Year Ended March 31, 2026 CI
05-13 MatsukiyoCocokara & Co. authorizes a Buyback Plan. CI
02-21 Az-COM MARUWA Holdings Inc. Announces Construction of AZ-COM Matsubushi WEST, a New Logistics Center CI
02-13 MatsukiyoCocokara & Co. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2026 CI
02-13 MatsukiyoCocokara & Co. Announces Executive and Board Changes, Effective April 1, 2026 CI
02-13 MatsukiyoCocokara & Co. Reports Earnings Results for the Nine Months Ended December 31, 2025 CI
12-31 Metagen Therapeutics, Inc. announced that it has received ¥3.52 billion in funding from a group of investors CI
1 day+0.35%
1 week+0.99%
Current month+0.99%
1 month-1.10%
3 months-4.80%
6 months-19.03%
Current year-15.45%
1 week 2,212.5
Extreme 2212.5
2,326
1 month 2,171.5
Extreme 2171.5
2,388
Current year 2,171.5
Extreme 2171.5
2,792.5
1 year 2,171.5
Extreme 2171.5
3,393
3 years 2,022
Extreme 2022
3,393
5 years 1,245
Extreme 1245
3,393
10 years 713.33
Extreme 713.3333
3,393
Manager TitleAgeSince
Director of Finance/CFO - -
President 53 01/04/2014
Chief Administrative Officer 63 01/04/2017
Director TitleAgeSince
Chairman 83 01/04/2009
Director/Board Member 53 01/10/2007
Director/Board Member 51 01/04/2014
Change 5d. change 1-year change 3-years change Capi.($)
+0.35%+0.99%-19.49%-12.59% 5.63B
+1.01%-1.30%-4.29%-22.57% 15.53B
+0.56%-1.10%-20.22%-26.13% 7.41B
+1.02%-5.87%-24.33%-30.60% 3.56B
-0.67%-2.69%-20.03%-45.19% 3.34B
-0.08%+0.21%-38.11%-5.59% 3.33B
-0.93%-3.45%-7.81%-41.00% 2.68B
-0.63%-2.20%-20.27%-6.11% 2.57B
-0.78%+4.49%+96.03% - 2.56B
+0.68%-6.43%-0.09%+41.83% 1.7B
Average +0.05%-1.42%-5.86%-16.44% 4.83B
Weighted average by Cap. +0.37%-1.23%-8.98%-20.72%

Financials

2026 2027 *
Net sales 1,115B 6.96B 6.02B 5.53B 5.2B 9.69B 663B 9.84B 65.71B 25.57B 321B 26.12B 25.55B 1,168B 7.29B 6.31B 5.79B 5.45B 10.15B 695B 10.31B 68.84B 26.79B 336B 27.37B 26.77B
Net income 57.14B 357M 309M 283M 267M 496M 33.98B 504M 3.37B 1.31B 16.43B 1.34B 1.31B 60.51B 378M 327M 300M 282M 526M 35.98B 534M 3.57B 1.39B 17.4B 1.42B 1.39B
Net Debt -121B -756M -655M -601M -566M -1.05B -72.09B -1.07B -7.15B -2.78B -34.86B -2.84B -2.78B -119B -740M -641M -588M -554M -1.03B -70.56B -1.05B -6.99B -2.72B -34.12B -2.78B -2.72B
Logo MatsukiyoCocokara & Co.
MatsukiyoCocokara & Co, formerly Matsumotokiyoshi Holdings Co Ltd, is engaged in retail business, wholesale business and management support business. Retail business is engaged in operating chain stores of drugstores and insurance pharmacies, opening and operating insurance dispensing pharmacies, dispatching pharmacists and others. Wholesale business purchases and sells products handled by group companies and business partners that engage in retail business, develops franchise businesses, and supplies products to franchisees. The Management Support segment is involved in the management of group companies and contracting of indirect business, planning and development of private brand products, asset management and operation, the construction and maintenance of stores, as well as the operation of non-life and life insurance agency business.
Employees
12,753
Date Price Change Volume
05/06/26 2,293.00 ¥ +0.35% 1,712,300
04/06/26 2,285.00 ¥ +1.65% 2,229,000
03/06/26 2,248.00 ¥ -2.05% 3,102,000
02/06/26 2,295.00 ¥ +0.44% 2,507,100
01/06/26 2,285.00 ¥ +0.64% 2,724,500
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
2,293.00JPY
Average target price
2,979.00JPY
Spread / Average Target
+29.92%

Quarterly revenue - Rate of surprise